People Plus Opposition, Rilpivirine, (Ea202391454)
No Annotations
Alert me when there are new annotations for this document
5 similar patent oppositions
-
LEK Pharmaceuticals opposition, Dolutegravir/Abacavir/Lamivudine , (EP2531027)
Countries: Europe (EPO) Date: 2016
-
Page White & Farrer opposition, Dolutegravir/Abacavir/Lamivudine , (EP2531027)
Countries: Europe (EPO) Date: 2016
-
ter Meer Steinmeister & Partner opposition, Dolutegravir/Abacavir/Lamivudine , (EP2531027)
Countries: Europe (EPO) Date: 2016
-
Vietnam Network of People Living with HIV (VNP+) opposition, Rilpivirine, (PCT/US2021/072453)
Countries: Viet Nam Date: 2025
-
Thai Network of People Living with HIV/AIDS (TNP+) opposition, Rilpivirine, (WO/2012/068535)
Countries: Thailand Date: 2025